JournalFrontiers in Oncology
PublisherFrontiers Media S.A.
MetadataShow full item record
AbstractAn international group of 22 liver cancer experts from 18 institutions met in Miami, Florida to discuss the optimal utilization of proton beam therapy (PBT) for primary and metastatic liver cancer. There was consensus that PBT may be preferred for liver cancer patients expected to have a suboptimal therapeutic ratio from XRT, but that PBT should not be preferred for all patients. Various clinical scenarios demonstrating appropriateness of PBT vs. XRT were reviewed. Copyright 2007 - 2019 Frontiers Media S.A. All Rights Reserved.
Hepatocellular carcinoma (HCC)
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85067651618&doi=10.3389%2ffonc.2019.00457&partnerID=40&md5=0e1ebb5c4121da353ef20a6c1aac2995; http://hdl.handle.net/10713/10582